Compounds > fluoxetine

fluoxetine and leucine

fluoxetine has been researched along with leucine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Schaechter, JD; Wurtman, RJ1
Suh, HH; Tseng, LL1
Idoate, I; Larralde, J; Urdaneta, E1
Dutertre, S; Lewis, RJ; Paczkowski, FA; Sharpe, IA1
Lewis, RJ; Ramu, S; Shaikh, NH; Wang, CI1

Other Studies

7 other study(ies) available for fluoxetine and leucine

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Serotonin release varies with brain tryptophan levels.
    Brain research, 1990, Nov-05, Volume: 532, Issue:1-2

    Topics: Animals; Biological Availability; Electric Stimulation; Fluoxetine; Hydroxyindoleacetic Acid; Hypothalamus; In Vitro Techniques; Leucine; Male; Membrane Potentials; Rats; Rats, Inbred Strains; Serotonin; Tryptophan

1990
Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
    Neuropharmacology, 1990, Volume: 29, Issue:3

    Topics: Analgesics; Animals; beta-Endorphin; Desipramine; Fluoxetine; Injections, Intraventricular; Injections, Spinal; Leucine; Male; Mice; Mice, Inbred ICR; Morphine; Reaction Time; Thiorphan

1990
Drug-nutrient interactions: inhibition of amino acid intestinal absorption by fluoxetine.
    The British journal of nutrition, 1998, Volume: 79, Issue:5

    Topics: Animals; Culture Techniques; Enzyme Inhibitors; Fluoxetine; Food-Drug Interactions; Intestinal Absorption; Intestinal Mucosa; Jejunum; Leucine; Male; Microvilli; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sodium-Potassium-Exchanging ATPase; Time Factors

1998
chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.
    The Journal of biological chemistry, 2007, Jun-15, Volume: 282, Issue:24

    Topics: Adrenergic alpha-Agonists; Amino Acid Sequence; Animals; Antidepressive Agents, Tricyclic; Biological Transport; Conotoxins; Crystallography, X-Ray; Dopamine; Fluoxetine; Glutamic Acid; Humans; Leucine; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Neurotoxins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Protein Isoforms; Protein Structure, Tertiary; Sequence Alignment

2007
A second extracellular site is required for norepinephrine transport by the human norepinephrine transporter.
    Molecular pharmacology, 2012, Volume: 82, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Animals; Binding Sites; Biological Transport; Chlorocebus aethiops; Computer Simulation; COS Cells; Fluoxetine; Humans; Leucine; Molecular Docking Simulation; Mutagenesis, Site-Directed; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins

2012